Navigation Links
Millennium Reports Outstanding Third-Quarter Results Driven by VELCADE(R) (Bortezomib) for Injection Sales
Date:11/1/2007

is and a growing percentage throughout the course of the

disease.

-- American Society of Hematology (ASH) Meeting -- Numerous VELCADE

abstracts are expected to be featured at the ASH meeting in December

2007. These abstracts may include data from two large, randomized

Phase III trials in patients with newly diagnosed MM. Data may also be

presented on additional VELCADE based combinations in front-line MM and

Non-Hodgkin's Lymphoma (NHL).

Clinical Pipeline Highlights

In addition to VELCADE, the Company continues to advance ten novel molecules in the areas of cancer and inflammatory diseases. Recent progress included the following:

-- MLN0002 - The Company completed enrollment in the bridging trials

designed to evaluate the safety, tolerability, pharmacokinetics and

pharmacodynamics of this novel antibody to the target alpha 4 beta 7,

derived from a new commercially scalable cell line. The Company is

tracking toward pivotal trials with MLN0002 in ulcerative colitis and

Crohn's disease.

-- MLN3897 - The Company is on track to announce top-line results for this

novel CCR1 inhibitor by year end from a 191-patient Phase II proof-of-

concept trial in rheumatoid arthritis.

-- MLN4924 - In October 2007, the Company presented data on this

Millennium-discovered molecule and target at the European Organization

for Research and Treatment of Cancer (EORTC) meeting. Data for this

inhibitor of the Nedd8-activating enzyme showed the molecule

significantly inhibited tumor growth in xenograft models for colorectal

cancer and several types of lymphoma. MLN4924 is expected to enter

Phase I trials in early 2008.

Conference Call and Presentation Reminder

Dr. Dunsire and members of the Millennium leadership team will present additional details on these results this m
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... Denver, CO (PRWEB) July 29, 2014 ... and soiled linen collection and transport solutions for hospitals, ... Society for Healthcare Engineering (ASHE) Annual Conference & Technical ... TransVac will present its technology for making hospitals cleaner, ... operational costs over the hospital’s life cycle. Staff ...
(Date:7/29/2014)... July 29, 2014 Genera ... feedstock supply innovation and supply chain advancements, has ... management systems, Energy Grange™ and Supply ASSURE™. ... and in-the-field testing aimed at consolidating and simplifying ... to landowners, farmers and feedstock end users. , ...
(Date:7/29/2014)... Quorum Review IRB, the industry leader ... by the International Association of Six Sigma ... Deployment Program. The citation recognizes robust organizational enhancements ... Lean Six Sigma program was evaluated by IASSC ... designation is a public statement of excellence and ...
(Date:7/29/2014)... 29, 2014 The first product launch ... generation approach to robotics. What sets Droidles completely apart ... technology that allows them to communicate, share code with ... the internet. , “The invention is the system,” said ... Droidles a life of their own, both physically and ...
Breaking Biology Technology:TransVac Presents Cost Saving Technology at ASHE Conference for Keeping Hospitals Cleaner 2Genera Energy Introduces Proprietary Feedstock Management Systems 2Genera Energy Introduces Proprietary Feedstock Management Systems 3Genera Energy Introduces Proprietary Feedstock Management Systems 4Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 2Quorum Review IRB Accredited by IASSC for Lean Six Sigma Deployment Program 3Droidles, the Social Network of Robots and Open Source Platform for the Internet of Things, Launches for Crowd Funding on IndieGoGo.com 2
... A discovery by scientists at the University of East ... that use domestic or agricultural waste to generate clean ... Proceedings of the National Academy of Sciences ... the mechanism by which some bacteria survive by ,breathing ...
... , , FREMONT, Calif., Dec. ... a leading developer of state-of-the-art genetic analysis systems, today ... Panel for its innovative service for gene-expression profiling using ... Panel provides the most comprehensive human microRNA panel of ...
... , , , , WALTHAM, Mass., Dec. ... research and advisory firms for pharmaceutical and healthcare issues, ... Ortho Biotech/Janssen-Cilag,s Stelara and Abbott,s briakinumab (both interleukin inhibitors) ... 2012 in the drug market for moderate to severe ...
Cached Biology Technology:'Rock-breathing' bacteria could generate electricity and clean up oil spills 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 2WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 3WaferGen to Launch Human MicroRNA Panel for Gene-Expression Profiling of 885 MicroRNA for Its Service Using the SmartChip(TM) Real-Time PCR System 4In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 2In 2012, Stelara and Briakinumab Will Capture 22 Percent of the Biologics Share in the Moderate to Severe Psoriasis Drug Market 3
(Date:7/29/2014)... the first to show that while the impact of ... negative effects may be reduced by maintaining a healthy ... participants who exercised, slept well and ate well had ... healthy lifestyles, even when they had similar levels of ... in the department of psychiatry at UCSF. "It,s very ...
(Date:7/28/2014)... discovery of two additional coral communities showing signs of damage ... of the 2010 spill in the Gulf of Mexico. The ... professor of biology at Penn State University. A paper describing ... in the Gulf of Mexico will be published during the ... of the journal Proceedings of the National Academy of ...
(Date:7/28/2014)... led by the University of Arizona has sequenced the ... will enhance scientists, and agriculturalists, understanding of the growing ... development of new rice varieties that are better able ... global hunger challenges. , The paper, "The genome sequence ... for independent domestication," was published online in Nature ...
Breaking Biology News(10 mins):Healthy lifestyle may buffer against stress-related cell aging, study says 2Impact of Deepwater Horizon oil spill on coral is deeper and broader than predicted 2Generating a genome to feed the world: UA-led team sequences African rice 2Generating a genome to feed the world: UA-led team sequences African rice 3Generating a genome to feed the world: UA-led team sequences African rice 4
... and the United States have completed the draft genome ... bacteria that cause citrus canker. Citrus canker, a belligerent ... the United States, South America, and Asia, causes millions ... of citrus crops such as oranges, limes, and grapefruit. ...
... evolve or not to evolve? That is the question scientists ... answering following a groundbreaking new study into the colourful hamlet ... in the vast marine environment. The new findings, published online ... significantly improve our understanding of speciation the evolutionary process ...
... defend themselves in some way, they would certainly be gobbled ... little insects to large mammalian herbivores. Indeed, not only ... kind of defense. When a plant has several options, ... the same tissues or defend different tissues in different ways? ...
Cached Biology News:Genomes of citrus canker pathogens decoded 2Genomes of citrus canker pathogens decoded 3Hamlet fish sheds light on evolution of marine species 2Making its predators tremble: Multiple defenses act synergistically in aspen 2Making its predators tremble: Multiple defenses act synergistically in aspen 3
... For the ultimate in utility and ... to meet the needs of the researcher. ... interior dimensions or as sheet material that ... enclosures. These isolators are autoclavable and non-cytotoxic ...
2,4-Dinitrophenyl hapten is conjugated to Human Serum Albumin (HSA) protein through lysine....
IC50: 3 ng/ml · Limit of detection: 0.5 ng/ml...
Antibodies were affinity purified using epitopes specific to PPP1CC immobilized on solid support....
Biology Products: